XML 32 R21.htm IDEA: XBRL DOCUMENT
v3.20.2

Stockholders' Equity | 9 Months Ended
--- | ---
Sep. 30, 2020
Equity [Abstract] |
Stockholders' Equity | Note 14—Stockholders’ equity: Accumulated Other Comprehensive Income – Changes in accumulated other comprehensive income (loss) attributable to Valhi stockholders are presented in the table below.
| Three months ended |  |  | Nine months ended |
| September 30, |  |  | September 30, |
| 2019 |  |  | 2020 |  |  | 2019 |  |  | 2020 |
| (In millions) |
Accumulated other comprehensive income (loss), net of tax and noncontrolling interest: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Marketable securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at beginning of period | $ | 1.7 |  |  | $ | 1.8 |  |  | $ | 1.7 |  |  | $ | 1.7 |
Other comprehensive loss - unrealized losses arising during the period |  | - |  |  |  | - |  |  |  | - |  |  |  | .1 |
Balance at end of period | $ | 1.7 |  |  | $ | 1.8 |  |  | $ | 1.7 |  |  | $ | 1.8 |
Currency translation adjustment: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at beginning of period | $ | (70.9 | ) |  | $ | (92.4 | ) |  | $ | (75.6 | ) |  | $ | (76.8 | )
Other comprehensive income (loss) |  | (12.6 | ) |  |  | 6.8 |  |  |  | (7.9 | ) |  |  | (8.8 | )
Balance at end of period | $ | (83.5 | ) |  | $ | (85.6 | ) |  | $ | (83.5 | ) |  | $ | (85.6 | )
Defined benefit pension plans: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at beginning of period | $ | (130.6 | ) |  | $ | (142.1 | ) |  | $ | (134.0 | ) |  | $ | (146.6 | )
Other comprehensive income - amortization of prior service cost and net losses included in net periodic pension cost |  | 1.7 |  |  |  | 2.3 |  |  |  | 5.1 |  |  |  | 6.8 |
Balance at end of period | $ | (128.9 | ) |  | $ | (139.8 | ) |  | $ | (128.9 | ) |  | $ | (139.8 | )
OPEB plans: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at beginning of period | $ | 1.3 |  |  | $ | .7 |  |  | $ | 1.7 |  |  | $ | 1.0 |
Other comprehensive loss - amortization of prior service credit and net losses included in net periodic OPEB cost |  | (.2 | ) |  |  | - |  |  |  | (.6 | ) |  |  | (.3 | )
Balance at end of period | $ | 1.1 |  |  |  | .7 |  |  | $ | 1.1 |  |  | $ | .7 |
Total accumulated other comprehensive income (loss): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at beginning of period | $ | (198.5 | ) |  | $ | (232.0 | ) |  | $ | (206.2 | ) |  | $ | (220.7 | )
Other comprehensive income (loss) |  | (11.1 | ) |  |  | 9.1 |  |  |  | (3.4 | ) |  |  | (2.2 | )
Balance at end of period | $ | (209.6 | ) |  | $ | (222.9 | ) |  | $ | (209.6 | ) |  | $ | (222.9 | )
Reverse stock split – On May 28, 2020 following stockholder approval at our annual meeting, our board of directors approved a reverse stock split of our common stock at a ratio of 1-for-12, which was effective on June 1, 2020. All share and per-share disclosures for all periods presented in our consolidated financial statements have been adjusted to give effect to the reverse stock split, and we have adjusted our stockholders’ equity at December 31, 2018, June 30, 2019, September 30, 2019 and December 31, 2019 to reflect the split by reclassifying $3.3 million from common stock to additional paid-in capital representing $.01 per share par value of each share of common stock eliminated as a result of the reverse stock split. Preferred stock – At December 31, 2019, our outstanding preferred stock consisted of 5,000 shares of our Series A Preferred Stock having a liquidation preference of $133,466.75 per share, or an aggregate liquidation preference of $667.3 million. The outstanding shares of Series A Preferred Stock were held by Contran and represented all of the shares of Series A Preferred Stock we were authorized to issue. The preferred stock had a par value of $.01 per share and paid a non-cumulative cash dividend at an annual rate of 6% of the aggregate liquidation preference only when authorized and declared by our board of directors. The shares of Series A Preferred Stock were non-convertible, and did not carry any redemption or call features (either at our option or the option of the holder). A holder of the Series A shares did not have any voting rights, except in limited circumstances, and was not entitled to a preferential dividend right that is senior to our shares of common stock. We have not declared any dividends on the Series A Preferred Stock since its issuance. Effective August 10, 2020, we, Contran and a wholly owned subsidiary of Contran entered into a contribution agreement pursuant to which on August 10, 2020, the 6% Series A Preferred Stock was voluntarily contributed to our capital for no consideration and without the issuance of additional securities by us. Our independent directors approved acceptance of such contribution and entering into the contribution a greement. The contribution has no impact on our consolidated financial position, results of operations or liquidity and the contribution did not have any tax consequences to us. On August 10, 2020, following the contribution of the 6% Series A Preferred Stock to us, we filed a Certificate of Elimination with the Secretary of State of Delaware and, as a result, the 5,000 shares that were designated as 6% Series A Preferred Stock have been returned to the status of authorized but unissued shares of the preferred stock, $.01 par value per share, without designation as to series. Other – During the first nine months of 2019, Kronos acquired 264,992 shares of its common stock in market transactions for an aggregate purchase price of $3.0 million and subsequently cancelled 110,303 shares, representing $1.4 million of such shares. During the first nine months of 2020, Kronos acquired 122,489 shares of its common stock in market transactions for an aggregate purchase price of $1.0 million and subsequently cancelled all such shares. At September 30, 2020, 1.6 million shares are available for repurchase under Kronos’ previously authorized stock repurchase program.

X
- Definition The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -URI http://asc.fasb.org/topic&trid=2134417 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(21)) -URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(23)) -URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(19)) -URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263 + Details
Name: | us-gaap_ComprehensiveIncomeNoteTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration